Thermo Fisher Scientific
S&P 500
$609.82
+1.10%
Delayed · cached 15 min
Peer comparison
| Company | Price↕ | Market Cap↕ | P/E↕ | P/B↕ | ROE %↕ | ROCE %↕ | Div yield %↕ | Valuation |
|---|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | $ 609.82 | $225.48B | 32.79 | 4.28 | 12.73 | 7.91 | 0.30 | Above FV |
| Danaher Corporation | $ 200.14 | $140.70B | 35.74 | 2.68 | 6.87 | 5.48 | 0.72 | Above FV |
| Waters Corporation | $ 408.34 | $40.09B | 103.12 | 2.64 | 4.23 | 3.41 | 0.00 | Above FV |
| IQVIA | $ 261.77 | $43.09B | 32.56 | 6.98 | 21.86 | 10.23 | 0.00 | Above FV |
| Agilent Technologies | $ 146.93 | $41.43B | 28.98 | 5.63 | 17.70 | 12.73 | 0.71 | Above FV |
| Illumina, Inc. | $ 206.45 | $31.17B | 38.45 | 10.98 | 29.95 | 15.93 | 0.00 | Above FV |
| Mettler Toledo | $ 1,293.52 | $25.92B | 29.15 | 2,021.13 | 6,778.39 | 42.42 | 0.00 | Above FV |
| Medpace | $ 587.52 | $16.40B | 34.46 | 37.79 | 103.98 | 74.98 | 0.00 | Above FV |
| Charles River Laboratories | $ 278.26 | $13.40B | -95.62 | 4.68 | -5.08 | 0.39 | 0.00 | — |
| Bio-Techne | $ 72.12 | $11.31B | 62.17 | 5.34 | 8.63 | 10.40 | 0.44 | Above FV |
| Bio-Rad Laboratories | $ 369.32 | $9.87B | 45.04 | 1.38 | 10.59 | 0.48 | 0.00 | Below FV |
| Avantor | $ 14.81 | $10.02B | -18.99 | 1.78 | -9.49 | -2.39 | 0.00 | — |
Price, market cap, P/E, P/B and dividend yield reflect the live quote (delayed, cached 15 min); ROE/ROCE from reported financials. The highlighted row is the current company. Click a column header to sort. Educational data only.
How to read the peer comparison
This table places the company beside others in the same industry on a few common measures. Comparison adds context that a single company's numbers cannot give on their own.
- Valuation multiples like P/E and P/B are most meaningful within the same industry, because different industries naturally trade at different levels. Comparing a company only to its peers is more useful than to the whole market.
- Return measures (ROE, ROCE) show how efficiently each company turns capital into profit. A company well ahead of or behind its peers here is worth understanding.
- No single column decides anything. A beginner reads the row across — valuation, returns, and size together — and treats the highlighted current company as one data point among its peers.
- Use the sortable headers to rank peers on any measure, but remember that "cheaper" or "higher" on one metric is a starting question, not an answer.
Educational only — not a recommendation to buy, sell, or hold any security.